We are building Diagnostic Infrastructure that should exist - but doesn't
SelfDiagnostics International develops early-warning diagnostics for diseases recognised too late. First product: BorreTest. Financial round in preparation.
Early clarity is better and cheaper than late diagnosis.
Lyme disease is the largest preventable damage in vector-borne infections in Europe.
Treated early, it costs €200–500 per case. In the late stage, €20,000–80,000 — meaning the ROI of timely information is 1:100 to 1:400.
This isn't a detail. It's the reason this market will form.
Three drivers converging right now
The problem is growing.
Tick populations are shifting north and uphill with the climate. The season is extending by weeks per decade. Lyme is no longer a southern European disease — it's arriving in the north.
Consumer diagnostics is normalised.
After the COVID years, willingness to pay for self-tests is structurally high. People ordering vitamin D tests today buy risk tests tomorrow. The threshold Roche and Abbott couldn't cross for decades has fallen.
Nobody is building the right thing.
Today's options are: wait, google, blood test in two weeks. Nobody tests the tick itself, with hardware in the user's hand, with data in a database that becomes more valuable with every test.
Sizable Market - Fitting Solution
>150 million annual tick bites in Europe and North America.
High tens of millions unable to evade the risk of tick-borne diseases, even if medical systems would run efficiently.
Problem awareness is very high - no solution yet.